According to the Zhitong Finance App, Dongrui Pharmaceutical (02348) announced that on November 5, 2026, the company will spend HK$2271,000 to repurchase 248,000 shares at a repurchase price of HK$0.91-0.92 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.